A Decision-Support Software to Improve the Standard Care in Chinese Type 2 Diabetes
Yingying Luo(Peking University), Linong Ji(Peking University), Yongzan Zhu(Chinese Medical Association), Xianghai Zhou(Peking University), Xiantong Zou(Peking University), Jing Chen(Shanghai Jiao Tong University), Wenjia Yang(Peking University), Xueying Gao(Shandong University)
Cited by 8
Related Papers
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
|Diabetes Care|2016|969
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses
|Diabetologia|2020|373
A Genome-Wide Association Study Identifies <i>GRK5</i> and <i>RASGRP1</i> as Type 2 Diabetes Loci in Chinese Hans
|Diabetes|2012|184
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
|Nature Medicine|2024|152
New insights into the treatment of obesity
|Diabetes Obesity and Metabolism|2023|148